Cas:14668-91-8 N-methyl-1-(5-methylfuran-2-yl)methanamine manufacturer & supplier

Chemical Name:N-methyl-1-(5-methylfuran-2-yl)methanamine

CAS.NO:14668-91-8

Synonyms:N,5-Dimethyl-2-Furanmethanamine

Molecular Formula:C₇H₁₁NO

Molecular Weight:125.16800

HS Code:2932190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:154.4ºC at 760 mmHg

Density:0.961g/cm3

Index of Refraction:1.473

PSA:25.17000

Exact Mass:125.08400

LogP:1.69830

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N,5-Dimethyl-2-Furanmethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,5-Dimethyl-2-Furanmethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,5-Dimethyl-2-Furanmethanamine Use and application,N,5-Dimethyl-2-Furanmethanamine technical grade,usp/ep/jp grade.

Related News: Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. N-methyl-1-(5-methylfuran-2-yl)methanamine manufacturer Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. N-methyl-1-(5-methylfuran-2-yl)methanamine supplier As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured. N-methyl-1-(5-methylfuran-2-yl)methanamine vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. N-methyl-1-(5-methylfuran-2-yl)methanamine factory Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).